Compound Detail
CHEMBL4073443
TOMIVOSERTIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL4073443 |
| Name | TOMIVOSERTIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | HKTBYUWLRDZAJK-UHFFFAOYSA-N |
15
Targets
25
Activities
2
Assay Types
8
PK Parameters
20
Publications
4
Known Names
8
Indications
1
Mechanisms
Molecular Properties
340.4
MW (Da)
1.63
ALogP
7
HBA
3
HBD
114.9
PSA (Ų)
0.77
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| MAP kinase-interacting serine/threonine-protein kinase 1/2 inhibitor | INHIBITOR | MAP kinase-interacting serine/threonine-protein kinase 1/2 | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Neoplasms Neoplasms Prostatic Neoplasms, Castration-Resistant Breast Neoplasms Leukemia, Myeloid, Acute Lymphoma
Activity Summary
IC50 23 meas. best 9.0
Ki 2 meas. best 8.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MAP kinase-interacting serine/threonine-protein kinase 2 CHEMBL4204 | IC50 | 9.0 | 8.91 | 1.0 | 4 |
| Eukaryotic translation initiation factor 4E CHEMBL4848 | IC50 | 8.85 | 8.4467 | 1.4 | 3 |
| MAP kinase-interacting serine/threonine-protein kinase 1 CHEMBL4718 | IC50 | 8.72 | 8.61 | 1.9 | 4 |
| MAP kinase-interacting serine/threonine-protein kinase 2 CHEMBL4204 | Ki | 8.52 | 8.52 | 3.0 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 1 CHEMBL4718 | Ki | 8.3 | 8.3 | 5.0 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 1/2 CHEMBL3883293 | IC50 | 8.22 | 8.22 | 6.0 | 1 |
| Mus musculus CHEMBL375 | IC50 | 7.8 | 7.8 | 15.8 | 1 |
| Serine/threonine-protein kinase 17A CHEMBL4525 | IC50 | 6.88 | 6.88 | 131.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 6.46 | 6.46 | 346.7 | 1 |
| Dual specificity protein kinase CLK4 CHEMBL4203 | IC50 | 6.1 | 6.1 | 787.0 | 1 |
| TMD8 CHEMBL4296503 | IC50 | 5.6 | 5.6 | 2530.0 | 1 |
| LN-18 CHEMBL4296458 | IC50 | 5.2 | 5.2 | 6270.0 | 1 |
| DOHH-2 CHEMBL2366181 | IC50 | 5.2 | 5.2 | 6300.0 | 1 |
| K562 CHEMBL385 | IC50 | 4.87 | 4.87 | 13540.0 | 1 |
| MV4-11 CHEMBL613835 | IC50 | 4.84 | 4.84 | 14490.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 4.53 | 4.53 | 29400.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.35 | 4.35 | 45000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 231.0 | - | Chlorocebus sabaeus |
| F | 79.0 | % | Mus musculus |
| F | 85.0 | % | Rattus norvegicus |
| F | 100.0 | % | Canis lupus familiaris |
| F | 24.0 | % | Macaca fascicularis |
| T1/2 | 2.0 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Canis lupus familiaris |
| T1/2 | 2.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine